openPR Logo
Press release

Aneurysmal Subarachnoid Hemorrhage Drugs Market is growing at a CAGR of 3.6% by 2023

05-11-2020 12:49 PM CET | Health & Medicine

Press release from: Allied Market Research

Aneurysmal Subarachnoid Hemorrhage Drugs Market

Aneurysmal Subarachnoid Hemorrhage Drugs Market

Global aneurysmal subarachnoid hemorrhage drugs market was valued at $160,269 thousand in 2016, and is estimated to reach $206,675 thousand by 2023, growing at a CAGR of 3.6% from 2017 to 2023.

Click Here To Access Free Sample Report: https://www.alliedmarketresearch.com/request-sample/4602

Aneurysmal subarachnoid hemorrhage is a kind of stroke, which is caused by bleeding in the subarachnoid space of the brain. The major reasons for aneurysmal subarachnoid hemorrhage include brain aneurysm, arteriovenous malformation, or head injury. Change in lifestyles such as smoking and alcohol consumption increase the risk for aSAH, as well as rise in geriatric population are the major factors that contribute to the growth of the market.

Moreover, increase in prevalence of hypertension, and stroke further boost the market growth. However, the associated side effects of the drugs are expected to impede the market growth. In addition, a need to create awareness about the optimal diagnosis and treatment of aneurysmal subarachnoid hemorrhage provide lucrative opportunities for the market growth.

Opioid analgesics generated the maximum revenue, accounting for more than two-fifths share of the global aneurysmal subarachnoid hemorrhage drugs market in 2016. The calcium channel blockers segment is expected to witness the highest CAGR of 4.5% during the forecast period, owing to their ability to reduce the risk of brain damage.

Key Findings of the Aneurysmal Subarachnoid Hemorrhage Drugs Market:
o The opioid analgesics segment is expected to grow at a significant CAGR of 2.6% during the forecast period.
o The anticonvulsants segment contributed nearly one-fourth share of the global aneurysmal subarachnoid hemorrhage drugs market in 2016.
o The stool softeners segment is projected to grow at a significant CAGR of 4.2% during the forecast period.
o Germany and France are the major shareholders, which collectively accounted for more than one-third share of the European aneurysmal subarachnoid hemorrhage drugs market in 2016.
o Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific aneurysmal subarachnoid hemorrhage drugs market in 2016.

For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/4602

The Asia-Pacific market is projected to grow at the highest CAGR of 5.5% during the forecast period, owing to rise in awareness about the treatment of aneurysmal subarachnoid hemorrhage in the healthcare industry and surge in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.

The major companies profiled in the report are Arbor Pharmaceuticals Inc., Edge Therapeutics, Inc., Johnson & Johnson (Actelion Pharmaceuticals Ltd.), Mylan N.V., Orexo AB, Pfizer Inc., Purdue Pharma L.P., Pharmaxis, Ltd., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd. (Cephalon, Inc.)

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web:https://www.alliedmarketresearch.com
Follow Us on LinkedIn:https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aneurysmal Subarachnoid Hemorrhage Drugs Market is growing at a CAGR of 3.6% by 2023 here

News-ID: 2040812 • Views: 184

More Releases from Allied Market Research

Ultrasonic Air Bubble Detectors Market Size & Share | Analysis - 2026
UPCOMING REPORT’S INTRODUCTION: According to an upcoming report of Allied Market Research, titled, “Ultrasonic Air Bubble Detectors Market”, the Ultrasonic Air Bubble Detectors market is expected to grow sustainably from 2020 to 2027. The report offers a comprehensive analysis of various growth drivers of the Ultrasonic Air Bubble Detectors market. The analysis ranges from revenue and operations to future growth opportunities. This comprehensive analysis of great importance for stakeholders to
World GPS Tracking Device Market - Opportunities and Forecasts, 2020-2027
Analyzing the current situation of pandemic, Allied market research has published a report t, which says, the GPS Tracking Device market is expected to grow at a faster pace by 2027. The researchers have intelligently made analysis and forecasts of the future growth by taking the past performance and data into consideration. The analysis offered by the report will surely provide valuable insights to the stakeholders of the GPS Tracking
Automotive Smart Helmet Market Statistics 2020: Advanced Technologies, Trends, C …
Allied Market Research published a new report, titled, "Automotive Smart Helmet Market." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain thorough understanding of the industry and determine steps to be taken to gain competitive advantage. Get detailed COVID-19 impact
Hybrid Funds Market Size, Share and Growth | Analysis - 2027
INTRODUCTION TO REPORT The report published by Allied market research, titled, “Hybrid Funds Market”, offers a comprehensive analysis of key growth drivers, key segments, development strategies, market opportunities, and competitive landscape. This study offers detailed insights for market players, investors, stakeholders, and new entrants to understand the industry dynamics and determine strategic steps to gain the competitive advantage. COVID_19 Scenarios: The Hybrid Funds has been the worst hit by COVID-19 globally. Based

All 5 Releases


More Releases for Aneurysmal

Aneurysmal Subarachnoid Hemorrhage Market Prospective Growth 2025 - Arbor Pharma …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market Preventing challenges complications 20 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Top Factors Driving the Global Aneurysmal Subarachnoid Hemorrhage Drugs Market
HTF MI recently introduced Global Aneurysmal Subarachnoid Hemorrhage Drugs Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. At present, the market is developing its presence and some of the key players from the complete study are Arbor Pharmaceuticals Inc. (US), Edge Therapeutics, Inc. (US), Johnson & Johnson (Actelion Pharmaceuticals Ltd.) (US), Mylan N.V. (US), Orexo AB (Sweden), Pfizer
Aneurysmal Subarachnoid Hemorrhage Market witness lethargic growth 2025
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market Dynamic Business Environment during 20 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market - Predicted Analysis and Forecast 2017 …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the